Your browser doesn't support javascript.
loading
Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Verhees, Myrthe J M; Engels, Manon; Span, Paul N; Sweep, Fred C G J; van Herwaarden, Antonius E; Falhammar, Henrik; Nordenström, Anna; Webb, Emma A; Richter-Unruh, Annette; Bouvattier, Claire; de la Perrière, Aude Brac; Arlt, Wiebke; Reisch, Nicole; Köhler, Birgit; Rapp, Marion; Stikkelbroeck, Nike M M L; Roeleveld, Nel; Claahsen-van der Grinten, Hedi L.
Afiliación
  • Verhees MJM; Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.
  • Engels M; Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.
  • Span PN; Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.
  • Sweep FCGJ; Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.
  • van Herwaarden AE; Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.
  • Falhammar H; Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, Netherlands.
  • Nordenström A; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
  • Webb EA; Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden.
  • Richter-Unruh A; Department of Women's and Children's Health, Division of Pediatric Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Bouvattier C; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom.
  • de la Perrière AB; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, United Kingdom.
  • Arlt W; Sektion Kinderendokrinologie und Diabetologie, Klinik für Kinder- und Jugendmedizin der Ruhr-Universität Bochum im St. Josef-Hospital, Bochum, Germany.
  • Reisch N; Endocrinologie Pédiatrique, Centre de Référence des Maladies Rares du Développement Sexuel, Hôpital Bicêtre, Université Paris-Sud, Le Kremlin-Bicêtre, France.
  • Köhler B; Fédération d'Endocrinologie, Centre de Référence des Maladies Rares du Développement Génital, Groupement Hospitalier Est, Hopital Louis Pradel, Bron, France.
  • Rapp M; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom.
  • Stikkelbroeck NMML; Institute of Metabolism and Systems Research (IMSR), University of Birmingham, Birmingham, United Kingdom.
  • Roeleveld N; Medizinische Klinik IV, Klinikum der Universität München, München, Germany.
  • Claahsen-van der Grinten HL; Klinik für Pädiatrie m.S. Endokrinologie und Diabetologie, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Front Endocrinol (Lausanne) ; 12: 626646, 2021.
Article en En | MEDLINE | ID: mdl-33815285
ABSTRACT
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a disorder of adrenal steroid biosynthesis, leading to hypocortisolism, hypoaldosteronism, and hyperandrogenism. Impaired quality of life (QoL) has been demonstrated in women with CAH, but data on men with CAH are scarce. We hypothesized that disease severity and poor treatment control are inversely associated with QoL. In this study, 109 men (16-68 years) with 21OHD were included. The WHOQOL-BREF questionnaire was used to measure self-reported QoL domain scores on a 0-100 scale, where higher scores reflect better QoL. QoL domain scores were compared to published data on healthy and chronically ill reference populations from France, Germany, the Netherlands, and the United Kingdom. Differences in QoL scores among groups of disease severity and treatment control were tested within the study population. Overall, the men with CAH in this study appeared to rate their QoL as good. Median domain scores were 78.6 (IQR 67.9-85.7) for physical health, 79.2 (IQR 66.7-87.5) for psychological health, 75.0 (IQR 58.3-83.3) for social relationships, and 81.3 (IQR 71.9-90.6) for environment. In general, these scores were similar to WHOQOL-BREF domain scores in healthy references and higher compared to chronically ill reference populations. The domain scores did not differ among genotype groups, but patients with undertreatment or increased 17-hydroxyprogestrone concentrations scored higher on several QoL domains (p<0.05). Patients treated with dexamethasone or prednisone scored higher on the physical health, psychological health, and social relationships domains, but not on the environmental domain. In conclusion, QoL domain scores appeared to be comparable to healthy reference populations and higher compared to patients with a chronic illness. QoL was not influenced by genotype, but undertreatment and use of dexamethasone or prednisone were associated with higher QoL.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Salud Mental / Hiperplasia Suprarrenal Congénita Tipo de estudio: Diagnostic_studies / Qualitative_research Límite: Adult / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Salud Mental / Hiperplasia Suprarrenal Congénita Tipo de estudio: Diagnostic_studies / Qualitative_research Límite: Adult / Humans / Male Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos